Cerebras Systems & Morgan Stanley

Cerebras Systems: Cerebras Systems experienced a significant surge in stock price and received overwhelmingly bullish ratings from nine major brokerages following the expiration of its post-IPO quiet period. This event highlights its strong position in the AI chip market, particularly for fast inference workloads.

Morgan Stanley: Morgan Stanley, an IPO bookrunner for Cerebras Systems, initiated coverage with an 'overweight' rating and a $250 price target, contributing to the positive sentiment around Cerebras Systems.

Cerebras Systems: Cerebras Systems' stock was up more than 4% after Wedbush initiated coverage with an 'outperform' recommendation.

Morgan Stanley: Morgan Stanley's strategist, Michael Wilson, offered an optimistic outlook on the market, suggesting the recent correction was healthy.

Cerebras Systems: Precedent for using 2028 revenue projections in IPO; its own IPO this year used similar forward-looking metrics.

Morgan Stanley: Morgan Stanley is one of the lead banks advising Anthropic on its IPO, positioning it to earn significant fees and enhance its reputation in tech IPOs.

Cerebras Systems: Cerebras Systems' recent IPO performance is mentioned as a reference point for market demand for AI companies, suggesting a positive sentiment for tech IPOs.

Morgan Stanley: Morgan Stanley is a co-lead underwriter for the SpaceX IPO and hosted a lunch meeting for institutional investors. Its analysts have made ambitious revenue projections for SpaceX's future.

Cerebras Systems: Cerebras Systems is mentioned as an example of a company whose IPO saw last-minute price raises, illustrating a common dynamic in IPOs that SpaceX is avoiding with its fixed price. This provides context on IPO mechanics.

Morgan Stanley: Morgan Stanley was a joint book-running manager for the SpaceX IPO, helping to manage the offering and earning substantial fees.

Cerebras Systems: Cerebras Systems uses SRAM memory, which is an IP provided by Marvell Technology, indicating a potential growth driver for Marvell Technology in the future.

Morgan Stanley: Morgan Stanley increased its target price for Marvell Technology stock, reflecting a bullish sentiment on the company's prospects.

Cerebras Systems: Cerebras' post-IPO decline is cited as a comparison.

Morgan Stanley: Morgan Stanley reiterated a $300 price target on SpaceX, showing bullish sentiment despite the stock's decline.